Back
MoonLake Immunotherapeutics Quote, Financials, Valuation and Earnings
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Buy
77
MLTX
MoonLake Immunotherapeutics
Last Price:
51.00
Seasonality Move:
10.4%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.MoonLake Immunotherapeutics Price Quote
$51.00
+0.01 (+2.04%)
(Updated: September 18, 2024 at 3:49 AM ET)
MoonLake Immunotherapeutics Key Stats
Buy
77
MoonLake Immunotherapeutics (MLTX)
is a Buy
Day range:
$47.70 - $51.09
52-week range:
$35.11 - $64.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.16%
Volume:
444.2K
Avg. volume:
241.5K
1-year change:
-9.3%
Market cap:
$3.2B
Revenue:
$0
EPS:
$-0.89
How Much Does MoonLake Immunotherapeutics Make?
Data Unavailable
Is MoonLake Immunotherapeutics Growing As A Company?
Data Unavailable
MoonLake Immunotherapeutics Stock Price Performance
-
Did MoonLake Immunotherapeutics Stock Go Up Last Month?
MoonLake Immunotherapeutics share price went up by 5.83% last month -
Did MLTX's Share Price Rise Over The Last Year?
MLTX share price fell by -9.3% over the past 1 year
What Is MoonLake Immunotherapeutics 52-Week High & Low?
-
What Is MoonLake Immunotherapeutics’s 52-Week High Share Price?
MoonLake Immunotherapeutics has traded as high as $64.98 over the past 52 weeks -
What Is MoonLake Immunotherapeutics’s 52-Week Low Share Price?
MoonLake Immunotherapeutics has traded as low as $35.11 over the past 52 weeks
MoonLake Immunotherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy MoonLake Immunotherapeutics?
-
How Much Debt Does MoonLake Immunotherapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does MoonLake Immunotherapeutics Have?
Cash and short term investments quarterly total is $519.8M -
What Is MoonLake Immunotherapeutics’s Book Value Per Share?
Book value per share is 8.28
Is MoonLake Immunotherapeutics Cash Flow Positive?
-
What Is MLTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$64.4M -
What Is MoonLake Immunotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $79.4M -
What Is MoonLake Immunotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$174.1M
MoonLake Immunotherapeutics Return On Invested Capital
Data Unavailable
MoonLake Immunotherapeutics Earnings Date & Stock Price
-
What Is MoonLake Immunotherapeutics's Stock Price Today?
A single share of MLTX can be purchased today for 50.99 -
What Is MoonLake Immunotherapeutics’s Stock Symbol?
MoonLake Immunotherapeutics trades on the nasdaq under the ticker symbol: MLTX -
When Is MoonLake Immunotherapeutics’s Next Earnings Date?
The next quarterly earnings date for MoonLake Immunotherapeutics is scheduled on November 14, 2024 -
When Is MLTX's next ex-dividend date?
MoonLake Immunotherapeutics's next ex-dividend date is September 18, 2024 -
How To Buy MoonLake Immunotherapeutics Stock?
You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
MoonLake Immunotherapeutics Competitors
-
Who Are MoonLake Immunotherapeutics's Competitors?
Below is a list of companies who compete with MoonLake Immunotherapeutics or are related in some way:
MoonLake Immunotherapeutics Dividend Yield
-
What Is MLTX Dividend Yield?
MoonLake Immunotherapeutics’s dividend yield currently is 0% -
What Is MoonLake Immunotherapeutics’s Payout Ratio?
MoonLake Immunotherapeutics’s payout ratio is 0% -
When Did MoonLake Immunotherapeutics Last Pay A Dividend?
The latest dividend pay date is September 18, 2024 -
What Is MoonLake Immunotherapeutics’s Dividend Per Share?
MoonLake Immunotherapeutics pays a dividend of $0.00 per share
MoonLake Immunotherapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -37.71% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 74.00 |
| Upside from Last Price: | 45.13% |